EvidentIQ
Serdar Kusaksizoglu is a seasoned finance professional with extensive experience in business control, reporting, and consulting. Currently serving as Group Business Controller at EvidentIQ since April 2023, Serdar is responsible for monthly and annual reporting as well as budgeting and forecasting. Previous roles include Business Consultant at SK-Consulting, Business Manager at Tech Data overseeing Google’s account, Controller at Ingram Micro and Konica Minolta, and Key Account Manager at Tech Data. Additionally, Serdar has a solid foundation in finance from a career beginning at Deutsche Telekom and an internship at BMW Group. Educational qualifications include a Bachelor Professional of Trade and Commerce, a Diplom in Groß- und Außenhandelskaufmann, and attendance at Üsküdar Anadolu Lisesi.
This person is not in any teams
EvidentIQ
EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end-to-end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs. EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China. -------------------------------- MORE ABOUT US: End-to-end eClinical Solution > Meeting increasing customerdemand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform, including EDC, CTMS, eTMF, eCOA, coding, remote monitoring, RBM, RTSM, Payments and eFeasibility. Patient Access > A digital CRO with a direct access to 500,000+ patients and caregivers allowing quick turnaround and cost- efficient patient recruitment and engagement. No doctor/ investigator/ patient advocacy groups bias in data collection. Geographical Reach > In-country patient communities platform in North America and Western Europe (EU5) and ability to conduct studies at a broader scale (LatAM, Asia...). Fast, flexible and focused services ranging from ‘full service’ to ‘do-it-yourself’. Select the services you require and create the ideal mix of professional study setup, consulting and training services to meet your specific needs. Data Science > Proprietary tools specifically designed to support our projects. In-house team able to quickly develop, adapt, and monitor.